Missing malaria? Potential obstacles to diagnosis and hypnozoite eradication

Karunajeewa, Harin; Waltmann, Andreea; Wini, Lyndes; Mueller, Ivo

doi:10.5694/mja14.01760

Topics

To the Editor: Bradbury and colleagues highlight some important challenges in managing Plasmodium vivax malaria when appropriate diagnostics and therapeutics are lacking.1

1 Walter and Eliza Hall Institute, Melbourne, VIC.
2 Western Health, Melbourne, VIC.
3 Ministry of Health, Honiara, Solomon Islands.

Correspondence: karunajeewa.h@wehi.edu.au

Competing interests:

No relevant disclosures.

1. Bradbury RS, Robertson G, Norton RE, Taylor-Robinson AW. Missing malaria? Potential obstacles to diagnosis and hypnozoite eradication. Med J Aust 2014; 201: 630-631. <MJA full text>
2. Knope KE, Doggett SL, Kurucz N, et al. Arboviral diseases and malaria in Australia, 2011–12: annual report of the National Arbovirus and Malaria Advisory Committee. Commun Dis Intell Q Rep 2014; 38: E122-E142.
3. Leder K, Torresi J, Brownstein JS, et al. Travel-associated illness trends and clusters, 2000–2010. Emerg Infect Dis 2013; 19: 1049-1073.
4. Murray CJ, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 1005-1070.
5. Betuela I, Rosanas-Urgell A, Kiniboro B, et al. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1–5 years of age. J Infect Dis 2012; 206: 1771-1780.

Online responses are no longer available. Please refer to our instructions for authors page for more information.